71 results about "Drynaria fortunei" patented technology

The invention provides an all-year cultivation method for drynaria fortunei seedlings. The all-year cultivation method includes the steps of treatment at the earlier stage, seeding, seedling separating and transplanting, field planting, managing after seeding and disease and pest prevention and treatment; the cultivated drynaria fortunei seedlings are high in resistance and wide in application range. During managing after seeding, the conditions of a culturing room are that illumination intensity is 30-50 micromole.m-2.s-1, the illumination period is 14-18 h / d, and temperature is 25+ / -2 DEG C; 50-60 days after seeding, deionized water starts to be sprayed, and 90-100 days after seeding, a 1 / 2 MS solution is sprayed one time every 8-12 days; preferably, the illumination period is 16 h / d, and a 1 / 2 MS solution starts to be sprayed one time every 10 days 90-100 days after seeding. The seedling cultivation technology is suitable for planting production of fields and protected areas. The all-year cultivation method is not limited by seeding seasons; the cultivated seedlings are high in adaptability, and the cultivation method is simple, efficient and easy to popularize.

The invention relates to the field of traditional Chinese medicinal formulations, particularly relates to an externally-applied medicinal preparation for treating hyperosteogeny, which is characterized in that the externally-applied medicinal preparation is prepared from the following raw materials in parts by weight: Rhododendron molle 15-20 parts, Pyrola rotundifolia 10-15 parts, Carthamus tinctorius flower 8-12 parts, Datura metel flower 10-12 parts, Pheretima 10-15 parts, Daemonorops draco 6-10 parts, Ligusticum chuanxiong 20-25 parts, Drynaria fortunei 6-8 parts, Impatiens balsamina 10-12 parts, Pittosporum tobira bark 12-15 parts, Chaenomeles speciosa fruit 15-20 parts, Eucommia ulmoides 8-10 parts, Hedera sinensis 12-16 parts, Spatholobus suberectus stem 6-10 parts, Angelica sinensis 15-20 parts, Curcuma longa 16-18 parts, Radix Paeoniae Rubra (Paeonia lactiflora and / or Paeonia veitchii) 12-16 parts, Moschus 3-5 parts, and camphor 3-5 parts by pulverizing the above raw materials into fine powder. The externally-applied medicinal preparation of the invention has low cost, high efficacy in treatment of hyperosteogeny, no toxic or side effect, and has effects of relieving exterior syndrome, dispelling cold, expelling wind and removing dampness, dredging blood stasis, smoothing collaterals, eliminating oppression of hyperosteogeny to nerve root, rapidly relieving pain and relieving numbness, repairing nerve atrophy and dissolving prominent hyperosteogeny neoplasms, so as to solve the problem from the source.

The invention relates to a traditional Chinese medicinal preparation for treating common nerve compression syndrome in loin cavity caused by hyperosteogeny. The preparation is available in the form of loins strengthening decoction or loins strengthening ointment, and is prepared from medicinal food stuffs and packaging material, wherein the medicinal food stuffs includes Eucommia ulmoides, herb pyrolae, longspur epimedium, Drynaria fortunei, Dipsacus asperoides, Cibotium barometz, Millettia speciosa Champ, Philippine Flemingia Root, Japanese raspberry root, Radix Angelicae Sinensis, Ligusticum chuanxiong, Radix Gentianae Macrophyllae, Salvia miltiorrhiza, safflower, Common Yam Rhizome, Indian Damnacanthus Herb, Lycopodium japonicum, Radix Clematidis, Selaginella tamariscina, Acanthopanax gracilistylus bark, pawpaw, lumbricus, Sarcandra glabra, Sinomenium acutum stem, Heterophyllous Wingseedtree, Common Jointfir Stem, Radix cynanchi paniculati, Homalomena occulta, Smallflower Magnoliavine Root, tiger urine, Grape Vine, Bittersweet, Tinosporasinensis (Lour.) Merr., Oriental Bittersweet Stem, Root of Greyblue Spicebush, Zaocys dhumnades, Xenochrophis piscator, Agkistrodon, pearl barley, processed Rehmannia glutinosa, Cornu cervi, Radix Ginseng, pig ridge ribs, duck eggs. The traditional Chinese medicinal preparation of the invention can be used for treating diseases such as common nerve compression syndrome in loin cavity caused by hyperosteogeny and the like, also can increase the blood flow volume of common nerve channel in lumbar spine bone cavity and microcirculation, repair lumbar spine cartilage pulp annulus, lock chondroitin and dissolve lumbar spine disc cartilage protrusion, which fills the gaps in new drug project field.

The present invention discloses a herbal composition for prevention and treatment of joint pain, the method of preparation thereof, and its application thereof. The composition relieves osteoarthritis pain and substantially treats osteoarthritis. It can be used for the prevention and treatment of osteoarthritis of various joints, including the knee joint, hip joint, wrist joint, spine joint, shoulder joint, and ankle joint. The composition disclosed herein can be formulated into tablet, capsule, dispersible tablet, chewable tablet, effervescent tablet, and buccal tablet. The composition comprises a mixture of glucosamine sulfate 2KCl, chondroitin sulfate, methyl-sulfonyl-methane (MSM), and any one or a combination of Sambucus williamsii Hance extract and Drynaria fortunei (Kunze) J. Sm. extract. Further, the mixture may comprise any one or a combination of type II collagen, Morinda officinalis root extract, Epimedium grandiflorum extract, and turmeric root extract. Preferably, the mixture is sieved and formulated into a dosage form with 0.10 g to 1.50 g of the mixture per dose. As compared to the prior art, the present invention offers advantages such as simple processing method, explicit functional components, and minimal side effects.

The invention relates to a product for patients with aseptic necrosis of femoral head, belonging to the field of traditional Chinese medicine. The product is mainly prepared from the following raw materials in parts by weight: 100-150 parts of Cornu Cervi Pantotrichum, 90-150 parts of Drynaria fortunei, 40-90 parts of Cucumis melo seed, 50-100 parts of Dipsacus asperoides, 60-100 parts of Acanthopanax gracilistylus bark, 50-100 parts of Cortex Eucommiae, 50-90 parts of Radix Astragali, 40-100 parts of Radix Codonopsis, 40-80 parts of processed rhizome corydalis, 30-80 parts of Radix Paeoniae, 30-60 parts of Carthamus tinctorius flower, 30-80 parts of Angelica sinensis, 40-80 parts of Eupolyphaga seu steleophaga, 30-60 parts of Acacia catechu, 30-80 parts of calcined pyrite, 30-70 parts of hirudo, and 10-30 parts of Radix Glycyrrhizae. The product provided by the invention has a unique formula, convenient preparation method, quick action, and is suitable for patients with aseptic necrosis of femoral head caused by traumata, hormone, long-term drinking and the like. Through clinical curative effect observation of more than 1,000 cases in 10 years, the curative ratio is up to 90%, and the effective rate is 95%.

The invention discloses a production method of a rhizoma drynariae extract. The production method comprises an extraction technology and a concentration technology, and further comprises a dearsenization technology, wherein the dearsenization technology comprises the steps of adding chitosan oligosaccharide and activated carbon to a concentrated solution obtained after concentration, and performing adsorption. According to the production method disclosed by the invention, the activated carbon and the chitosan oligosaccharide are used for adsorbing and removing heavy metal arsenic elements in the rhizoma drynariae extraction solutions, so that higher retention rate of naringin is guaranteed, and the removing rate of arsenic is greatly increased. Through verification with pilot scale production and amplification production, the method is efficient and low in cost, and is suitable for the trade of drugs and foods.